Iveda director reports 100K option repricing

Iveda Solutions director Joseph A. Farnsworth reported option transactions tied to an option repricing.

Rhea-AI Filing Summary

Iveda Solutions director Joseph A. Farnsworth reported option transactions tied to an option repricing. On February 23, 2026, he acquired 100,000 stock options at an exercise price of $0.29 per share and disposed of 100,000 options back to the company, with other option terms remaining unchanged.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Farnsworth Joseph A.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Options (Right to Buy)	100,000	$0.00	$0.00
Disposition	Options (Right to Buy)	100,000	$0.00	$0.00

Holdings After Transaction: Options (Right to Buy) — 257,198 contracts (Direct)

Footnotes (1)

1. F1. On February 23, 2026, the Issuer's Board of Directors approved an option repricing (the "Repricing") whereby the Reporting Person's options were repriced to an exercise price of $0.29 per share. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did IVDA director Joseph A. Farnsworth report?

Joseph A. Farnsworth reported acquiring 100,000 stock options and disposing of 100,000 stock options. These transactions are connected to an option repricing approved by Iveda Solutions’ board, which reset the exercise price while keeping all other option terms the same.

What was the new exercise price for Joseph Farnsworth’s IVDA options?

The options held by Joseph Farnsworth were repriced to an exercise price of $0.29 per share. The board-approved repricing adjusted only the exercise price, with all other terms of the stock options remaining unchanged according to the reported footnote.

Why did IVDA record both an acquisition and a disposition of 100,000 options?

The filing shows an acquisition of 100,000 options and a disposition of 100,000 options tied to a board-approved repricing. This structure reflects how the repricing was recorded, while the footnote notes that only the exercise price changed and other option terms remained the same.

What do the Form 4 transaction codes A and D mean for IVDA?

Code A indicates a grant, award, or other acquisition of derivative securities, while code D reflects a disposition to the issuer. In this case, both codes relate to the same option repricing event, rather than open-market trading activity in Iveda Solutions stock.

Were Joseph Farnsworth’s IVDA option transactions exempt under SEC rules?

Yes. The footnote states the option repricing transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 under the Exchange Act. Those provisions generally cover certain issuer-related transactions and board-approved equity compensation changes for insiders.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/25/2026 - 04:30 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Farnsworth Joseph A.

(Last) (First) (Middle)

1744 S. VAL VISTA DRIVE,

STE. 213

(Street)

MESA AZ 85204

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Iveda Solutions, Inc. [ IVDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options (Right to Buy)	$0.82	12/29/2025		D		100,000		12/29/2025	12/29/2035	Common Stock	100,000	$0.00	128,599	D
Options (Right to Buy)	$0.29(1)	02/23/2026		A		100,000		12/29/2025	12/29/2035	Common Stock	100,000	$0.00	128,599	D

Explanation of Responses:

1. On February 23, 2026, the Issuer's Board of Directors approved an option repricing (the "Repricing") whereby the Reporting Person's options were repriced to an exercise price of $0.29 per share. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

	/s/ Farnsworth Joseph A.	02/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.